Femara (letrozole) is a brand-name oral tablet that your doctor may prescribe off-label for infertility. The drug is not approved for this use, but it has been shown to be helpful in treating ...

The hysterosalpingography confirmed that there were no issues with my fallopian tubes!✨Furthermore, it seems that the six ...

Femara (letrozole) is a brand-name oral tablet that’s prescribed for certain types of breast cancer. As with other drugs, Femara can cause side effects, such as weight changes, joint pain, and low ...

"¢ Post-unblinding analysis of MA-17 trial data provides evidence for potential benefit of starting Femara up to seven years after finishing tamoxifen "¢ Femara only member of aromatase inhibitor ...

Femara (letrozole) is used to treat postmenopausal women with hormone receptor-positive breast cancer. This type of breast cancer uses the hormone estrogen as fuel. Femara reduces the amount of ...

Femara showed reduced risk of death by 13% (P=0.08), despite inclusion of patients crossing over from tamoxifen to Femara therapy In a separate censored analysis excluding patients after they crossed ...

Newswise — Women may reduce the risk of their breast cancer returning by starting treatment with Femara® (letrozole) anywhere from one to seven years after finishing tamoxifen therapy, according to a ...

Femara (letrozole, Novartis) has received FDA approval for use in treating early breast cancer in postmenopausal women following surgery. The agency based its approval on findings from the BIG I-98 ...

New research backs up earlier reports that the breast cancer drug Femara can reduce the risk of breast cancer recurrence by nearly 50 percent in women previously treated with tamoxifen. A five-year ...

It's official: Femara beats tamoxifen in preventing breast-cancer recurrence. A large 27-nation clinical trial shows that postmenopausal women with estrogen-receptor-positive breast cancer are less ...

CHICAGO (Reuters) - Taking the breast cancer pill Femara can significantly reduce the chances that a woman's cancer will return, even long after she has stopped taking the estrogen blocker tamoxifen, ...